PCCA recognized Jody Gilby as Pharmacist of the Year and Justine Magnus as Technician of the Year during its 2026 CONNEXT conference in Edmonton. The awards highlight contributions toward personalized medicine within Canada's pharmacy community. Read More »
Jonathan Levitt of Frier Levitt said three federal lawsuits allege CVS Health entities diverted approximately $250 million in 340B program savings from hospitals. Read More »
The Cannabis Regulatory Agency is inviting applications for its Diversity, Equity, and Inclusion Workgroup. Interested individuals must submit required information via email by June 4 at 5:00 PM. Selected members will help shape policies affecting their communities. Read More »
Sally Pipes of Pacific Research Institute called for greater congressional oversight and transparency in the federal 340B Drug Pricing Program. Read More »
Tennessee has passed a new law banning pharmacy benefit managers from owning pharmacies after significant lobbying efforts against it. The measure is intended to prevent conflicts of interest in healthcare delivery according to supporters. Read More »
Michigan officials urge residents to follow key safety tips when grilling or using fireworks this Memorial Day weekend. The guidance aims to reduce preventable fires or injuries during holiday celebrations. Read More »
Anne McDonald Pritchett said that pharmacy benefit managers—not patents—are limiting patient access to lower-cost biosimilars through their business practices. Read More »
Ryan Long of Paragon Health Institute said most 340B revenue goes to large hospital systems instead of struggling hospitals and called for reforms targeting spread gaming. Read More »
West Cuthbert of American Resolve Action urged congressional Republicans on May 4 to back efforts by the Trump administration aimed at increasing transparency in the federal 340B Drug Pricing Program through a rebate-based pilot. Read More »
The National Community Pharmacists Association has voiced support for two key bills under consideration in U.S. House committees: one targeting kickbacks involving pharmacy benefit managers; another expanding pharmacists' roles in patient care under Medicare. Read More »
The National Community Pharmacists Association commented on a recent federal watchdog report about vertical integration among Medicare Part D providers. CEO B. Douglas Hoey raised concerns about higher out-of-pocket costs for patients and limited transparency regarding pharmacy payments. Read More »
South Dakota has awarded initial contracts under its Rural Health Transformation initiative aimed at strengthening healthcare access in rural areas. The announcement includes new roles for North Star Solutions LLC., Black Hills Special Services Cooperative, and Business Concepts & Applications (BCA). State leaders say these steps mark progress toward modernizing healthcare delivery. Read More »
Paragon Health Institute called attention to ACA-driven expansion of hospital eligibility for the federal 340B drug pricing program. Read More »
Community Oncology Alliance Executive Director Ted Okon said expanding 340B eligibility to community practices would not address the federal drug pricing program’s underlying problems. Read More »
Joe Grogan of USC Schaeffer Center said Congress must act on what he described as an out-of-control 340B drug pricing program. Read More »
Rep. Diana Lynn Harshbarger called for greater transparency in the pharmacy benefit manager industry on May 18. Read More »
Katy Talento questioned why Medicare relies on pharmacy benefit managers instead of negotiating directly with pharmaceutical companies. Read More »
The Wall Street Journal Editorial Board highlighted a federal court decision blocking North Dakota’s 340B law on May 7. Read More »
The Michigan Department of Licensing and Regulatory Affairs has released a new consumer guide for home improvement projects. The publication provides tips on hiring contractors and avoiding fraud. Officials hope it will help residents protect their investments. Read More »
Sally Pipes of Pacific Research Institute said new federal proposals could bring needed transparency and accountability to the expanding 340B Drug Pricing Program. Read More »
Alerts Sign-up
